178 related articles for article (PubMed ID: 9135550)
1. Spontaneous priming for anti-viral envelope cytotoxic T lymphocytes in mice transgenic for a murine leukaemia virus envelope gene (Fv4).
Nihrane A; Silver J
Immunology; 1997 Feb; 90(2):219-28. PubMed ID: 9135550
[TBL] [Abstract][Full Text] [Related]
2. Retroviral infection in vivo requires an immune escape virulence factor encrypted in the envelope protein of oncoretroviruses.
Schlecht-Louf G; Renard M; Mangeney M; Letzelter C; Richaud A; Ducos B; Bouallaga I; Heidmann T
Proc Natl Acad Sci U S A; 2010 Feb; 107(8):3782-7. PubMed ID: 20142478
[TBL] [Abstract][Full Text] [Related]
3. FBL-reactive CD8+ cytotoxic and CD4+ helper T lymphocytes recognize distinct Friend murine leukemia virus-encoded antigens.
Klarnet JP; Kern DE; Okuno K; Holt C; Lilly F; Greenberg PD
J Exp Med; 1989 Feb; 169(2):457-67. PubMed ID: 2562982
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic T lymphocyte responses to the envelope proteins of endogenous ecotropic and mink cytopathic focus-forming murine leukemia viruses in H-2b mice.
Coppola MA; Green WR
Virology; 1994 Jul; 202(1):500-5. PubMed ID: 7516600
[TBL] [Abstract][Full Text] [Related]
5. T-lymphocyte priming and protection against Friend leukemia by vaccinia-retrovirus env gene recombinant.
Earl PL; Moss B; Morrison RP; Wehrly K; Nishio J; Chesebro B
Science; 1986 Nov; 234(4777):728-31. PubMed ID: 3490689
[TBL] [Abstract][Full Text] [Related]
6. Cell-free transmission of Fv-4 resistance gene product controlling Friend leukemia virus-induced leukemogenesis: a unique mechanism for interference with viral infection.
Kitagawa M; Aizawa S; Kamisaku H; Ikeda H; Hirokawa K; Sado T
Blood; 1995 Aug; 86(4):1557-63. PubMed ID: 7632964
[TBL] [Abstract][Full Text] [Related]
7. Vaccination with an adenoviral vector that encodes and displays a retroviral antigen induces improved neutralizing antibody and CD4+ T-cell responses and confers enhanced protection.
Bayer W; Tenbusch M; Lietz R; Johrden L; Schimmer S; Uberla K; Dittmer U; Wildner O
J Virol; 2010 Feb; 84(4):1967-76. PubMed ID: 20007267
[TBL] [Abstract][Full Text] [Related]
8. Friend virus-specific cytotoxic T lymphocytes recognize both gag and env gene-encoded specificities.
Holt CA; Osorio K; Lilly F
J Exp Med; 1986 Jul; 164(1):211-26. PubMed ID: 2425028
[TBL] [Abstract][Full Text] [Related]
9. Different H-2 subregions influence immunization against retrovirus and immunosuppression.
Morrison RP; Earl PL; Nishio J; Lodmell DL; Moss B; Chesebro B
Nature; 1987 Oct 22-28; 329(6141):729-32. PubMed ID: 2823142
[TBL] [Abstract][Full Text] [Related]
10. Interference of retroviral envelope with vaccine-induced CD8
Bongard N; Lapuente D; Windmann S; Dittmer U; Tenbusch M; Bayer W
Retrovirology; 2017 Apr; 14(1):28. PubMed ID: 28449719
[TBL] [Abstract][Full Text] [Related]
11. Secretion of a murine retroviral Env associated with resistance to infection.
Nihrane A; Lebedeva I; Lyu MS; Fujita K; Silver J
J Gen Virol; 1997 Apr; 78 ( Pt 4)():785-93. PubMed ID: 9129650
[TBL] [Abstract][Full Text] [Related]
12. Peptide-induced immune protection of CD8+ T cell-deficient mice against Friend retrovirus-induced disease.
Kawabata H; Niwa A; Tsuji-Kawahara S; Uenishi H; Iwanami N; Matsukuma H; Abe H; Tabata N; Matsumura H; Miyazawa M
Int Immunol; 2006 Jan; 18(1):183-98. PubMed ID: 16352628
[TBL] [Abstract][Full Text] [Related]
13. Transgenic Fv-4 mice resistant to Friend virus.
Limjoco TI; Dickie P; Ikeda H; Silver J
J Virol; 1993 Jul; 67(7):4163-8. PubMed ID: 8510219
[TBL] [Abstract][Full Text] [Related]
14. Dissecting the immune response to moloney murine sarcoma/leukemia virus-induced tumors by means of a DNA vaccination approach.
Milan G; Zambon A; Cavinato M; Zanovello P; Rosato A; Collavo D
J Virol; 1999 Mar; 73(3):2280-7. PubMed ID: 9971811
[TBL] [Abstract][Full Text] [Related]
15. Distribution of Fv-4 resistant gene product in Friend leukemia virus-resistant Fv-4r mouse strain.
Kitagawa M; Aizawa S; Kamisaku H; Sado T; Ikeda H; Hirokawa K
Exp Hematol; 1996 Oct; 24(12):1423-31. PubMed ID: 8913289
[TBL] [Abstract][Full Text] [Related]
16. Host genetic factors that control immune responses to retrovirus infections.
Miyazawa M; Tsuji-Kawahara S; Kanari Y
Vaccine; 2008 Jun; 26(24):2981-96. PubMed ID: 18255203
[TBL] [Abstract][Full Text] [Related]
17. Murine leukemia virus envelope protein in transgenic-mouse serum blocks infection in vitro.
Nihrane A; Fujita K; Willey R; Lyu MS; Silver J
J Virol; 1996 Mar; 70(3):1882-9. PubMed ID: 8627713
[TBL] [Abstract][Full Text] [Related]
18. Identification of an epitope encoded in the env gene of Friend murine leukemia virus recognized by anti-Friend virus cytotoxic T lymphocytes.
Ruan KS; Lilly F
Virology; 1991 Mar; 181(1):91-100. PubMed ID: 1704662
[TBL] [Abstract][Full Text] [Related]
19. Endogenous retroviral env expression in primary murine leukemias: lack of xenotropic antigens but presence of distinct mink cell focus-forming env subtypes correlating with ecotropic virus inoculated and mouse strain.
Cloyd MW; Evans LH
J Natl Cancer Inst; 1987 Jan; 78(1):181-9. PubMed ID: 3025502
[TBL] [Abstract][Full Text] [Related]
20. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. III. Coordinate alterations in viral gp70 antigen expression and restoration of CTL-susceptibility to insusceptible variant tumors.
Manjunath R; Graziano RF; Green WR
J Immunol; 1986 Mar; 136(6):2271-9. PubMed ID: 3005407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
